Michael A Arnold Selected Research

Drug Therapy (Chemotherapy)

1/2023	Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.
1/2023	Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
11/2022	Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort.
1/2022	Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
12/2019	Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
12/2019	Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study.
1/2017	Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
12/2015	Neutropenic Enterocolitis: New Insights Into a Deadly Entity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Arnold Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 09/2009
6	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2019
3	Thyroid Neoplasms (Thyroid Cancer) 03/2024 - 12/2019
3	Sarcoma (Soft Tissue Sarcoma) 10/2020 - 12/2019
2	Genetic Predisposition to Disease (Genetic Predisposition) 03/2024 - 01/2023
2	Basal Cell Carcinoma (Rodent Ulcer) 03/2024 - 01/2020
2	Appendicitis 01/2022 - 01/2015
2	Inflammation (Inflammations) 01/2022 - 11/2016
2	Hirschsprung Disease (Hirschsprung's Disease) 01/2022 - 10/2019
2	Rhabdomyosarcoma 01/2021 - 07/2015
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 07/2015
2	Meningioma (Meningiomas) 01/2020 - 01/2017
2	Leukemia 12/2019 - 09/2009
1	Genetic Risk Score 03/2024
1	Cytomegalovirus Infections (Inclusion Disease) 01/2022
1	Hyperplasia 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Disease Progression 01/2022
1	Eosinophilic Esophagitis 01/2022
1	Lymphoma (Lymphomas) 12/2019
1	Melanoma (Melanoma, Malignant) 12/2019
1	Infections 10/2019
1	Intestinal Diseases (Diseases, Intestinal) 10/2019
1	Carcinoid Tumor (Carcinoid) 10/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Neurofibrosarcoma (MPNST) 10/2017
1	Plexiform Neurofibroma 10/2017
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Helicobacter Infections 11/2016
1	Neutropenia 12/2015
1	Neutropenic Enterocolitis 12/2015
1	Weight Loss (Weight Reduction) 07/2015
1	Ulcerative Colitis 01/2015
1	Diverticulitis 01/2015
1	Fistula 01/2015
1	Adenocarcinoma 01/2015
1	Peritoneal Panniculitis (Sclerosing Mesenteritis) 01/2015
1	Abdominal Pain (Pain, Abdominal) 05/2013
1	Fever (Fevers) 05/2013
1	Diarrhea 05/2013
1	Autosomal Recessive 3 Severe Congenital Neutropenia 05/2013

Drug/Important Bio-Agent (IBA)

4	AnthracyclinesIBA 01/2023 - 12/2019
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
2	Alkylating AgentsIBA 12/2019 - 12/2019
2	Transcription Factors (Transcription Factor)IBA 09/2009 - 03/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2023
1	Anaplastic Lymphoma KinaseIBA 09/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	AntibodiesIBA 09/2022
1	WT1 ProteinsIBA 09/2022
1	A-factor (Streptomyces)IBA 01/2022
1	PeriostinIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	MyoD1 myogenic differentiation proteinIBA 01/2021
1	NucleotidesIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Proto-Oncogene Proteins c-metIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	rilotumumabIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	ORALIT (ORS)IBA 12/2019
1	Estrogen ReceptorsIBA 12/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2019
1	Calbindin 2IBA 10/2019
1	Hematoxylin (Haematoxylon)IBA 10/2019
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 10/2017
1	AntralIBA 11/2016
1	Taxoids (Taxanes)IBA 07/2015
1	Antimitotic AgentsIBA 07/2015
1	Albumin-Bound Paclitaxel FDA Link 07/2015
1	130-nm albumin-bound paclitaxelIBA 07/2015
1	N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA 07/2015
1	InterferonsIBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	CytokinesIBA 01/2015
1	AntigensIBA 01/2015
1	A 7 (A-7)IBA 05/2013
1	Growth Hormone (Somatotropin)IBA 05/2013
1	calcium phosphateIBA 04/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2013
1	CaveolinsIBA 04/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	Caveolin 1IBA 04/2013

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2023 - 12/2015
7	Radiotherapy 03/2024 - 01/2017
7	Therapeutics 09/2023 - 07/2015
2	Appendectomy 01/2022 - 10/2019
2	Immunotherapy 10/2017 - 04/2016
1	Aftercare (After-Treatment) 11/2022
1	Combined Modality Therapy 01/2022
1	Splenectomy 01/2017
1	Stents 01/2015